GPT Analysis
Empower Your Investments! Unleash the Potential with Smart Stock Analysis!
| Symbol | Company Name | Rating | Recommendation | Evaluation from GPT | Action | Time |
|---|---|---|---|---|---|---|
| SUZLON | Suzlon Energy Limited | 60 | Neutral | Suzlon Energy Limited (SUZLON.NS) is an Indian renewable energy company primarily engaged in wind power generation. The company has a market capitalization of INR 995,144,468,169.30 and a total of 13,645,200,384 shares outstanding. The stock has experienced a year-to-date change of 1.42% and currently trades at INR 72.93 per share. The stock's day high and day low were INR 75.45 and INR 72.40 respectively, indicating moderate price volatility. The fifty-day average and two-hundred day average are INR 77.70 and INR 53.98 respectively, indicating a Overall, the sentiment towards Suzlon Energy Limited is neutral. While the stock has shown some | | 2024-10-17 09:38:42 |
| SUVIDHAA | Suvidhaa Infoserve Limited | None | None | None | | None |
| SUVIDHAA | Suvidhaa Infoserve Limited | None | None | None | | None |
| SUVIDHAA | Suvidhaa Infoserve Limited | None | None | None | | None |
| SUVIDHAA | Suvidhaa Infoserve Limited | None | None | None | | None |
| SUVENPHAR | Suven Pharmaceuticals Limited | 80 | Positive | Suven Pharmaceuticals Limited (SUVENPHAR.NS) is a drug manufacturer specializing in specialty and generic drugs. The company operates in the healthcare sector and has a market capitalization of INR 132,501,078,016. Suven Pharmaceuticals has shown consistent growth with a trailing PE ratio of 32.25 and a profit margin of 31.45%. The company's revenue has been growing at a rate of 2.6% and its earnings have grown by 12.3% in the last quarter. Suven Pharmaceuticals has a strong balance sheet with a debt-to-equity ratio of 4.05 and a cash per share of INR 19.14. The stock has a 52-week high of INR 534.55 and a 52-week low of INR 390.5. Based on these factors, Suven Pharmaceuticals appears to be a promising investment option in the healthcare sector. | | 2023-08-18 10:29:42 |
| SUVENPHAR | Suven Pharmaceuticals Limited | None | None | None | | None |
| SUVENPHAR | Suven Pharmaceuticals Limited | None | None | None | | None |
| SUVENPHAR | Suven Pharmaceuticals Limited | None | None | None | | None |
| SUVEN | Suven Life Sciences Limited | 60 | Positive | Suven Life Sciences Limited (SUVEN.NS) is a drug manufacturer specializing in specialty and generic drugs. The company operates in the healthcare sector and has 132 full-time employees. SUVEN.NS has a market capitalization of INR 14,621,861,888 and a beta of 1.63, indicating moderate volatility compared to the market. The stock has a forward price-to-earnings ratio of 3.47, suggesting it may be undervalued. However, it is important to note that the company has | | 2023-08-18 10:29:08 |
| SUVEN | Suven Life Sciences Limited | None | None | None | | None |
| SUVEN | Suven Life Sciences Limited | None | None | None | | None |
| SUVEN | Suven Life Sciences Limited | None | None | None | | None |
| SUULD | Suumaya Industries Limited | None | None | None | | None |
| SUULD | Suumaya Industries Limited | None | None | None | | None |
| SUULD | Suumaya Industries Limited | None | None | None | | None |
| SUULD | Suumaya Industries Limited | None | None | None | | None |
| SUTLEJTEX | Sutlej Textiles and Industries Limited | None | None | None | | None |
| SUTLEJTEX | Sutlej Textiles and Industries Limited | None | None | None | | None |
| SUTLEJTEX | Sutlej Textiles and Industries Limited | None | None | None | | None |